We also discuss potential mechanisms and the major pathways of oxidative stress underlying PAD progression, including the role of the nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2) master antioxidant pathway as well as activation of the receptor for advanced glycation end products (RAGE). This evidence concerns the gene AGER and peripheral arterial disease.